You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymoma

Showing 1 - 25 of 219
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

Recruiting
  • Stage III Thymoma AJCC v8
  • +6 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Thymoma Trial in Shanghai, Zhejiang (RATS for Thymectomy, VATS for Thymectomy)

Not yet recruiting
  • Thymoma
  • RATS for Thymectomy
  • VATS for Thymectomy
  • Shanghai, Shanghai, China
  • +1 more
Sep 7, 2023

Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus

Not yet recruiting
  • Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
  • NAB-Paclitaxel plus Cisplatin
  • Cisplatin plus Epirubicin plus Cyclophosphamide
  • Shanghai, Shanghai, China
    Yian Zhang
Apr 17, 2023

Thymoma and Thymic Carcinoma Trial in Rozzano (Everolimus)

Completed
  • Thymoma and Thymic Carcinoma
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Recurrent Malignant Thymoma, Thymoma Trial in Houston (Diaphragm Fluoroscopy, Magnetic Resonance Imaging)

Active, not recruiting
  • Recurrent Malignant Thymoma
  • Thymoma
  • Diaphragm Fluoroscopy
  • Magnetic Resonance Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

Not yet recruiting
  • Thymoma
  • level of IL-8+ initial T cells
  • (no location specified)
Jul 23, 2022

NSCLC, Mesothelioma, Thymoma Trial in Breda, Dordrecht (Folinic acid)

Recruiting
  • NSCLC
  • +2 more
  • Folinic acid
  • Breda, Noord Brabant, Netherlands
  • +1 more
Aug 17, 2023

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Ocular Myasthenia Gravis Trial in Xi'an (Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus,

Recruiting
  • Ocular Myasthenia Gravis
  • Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
  • Xi'an, Shaanxi, China
    Tangdu Hospotal
Aug 16, 2022

Thymoma Malignant Recurrent Trial in France (Radiotherapy, Surveillance after resection)

Recruiting
  • Thymoma Malignant Recurrent
  • Radiotherapy
  • Surveillance after resection
  • Angers, France
  • +17 more
Aug 8, 2022

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Thymoma, Myasthenia Gravis Associated With Thymoma, Thymectomy Trial in Shanghai (Sigle port RATS, Two ports RATS)

Recruiting
  • Thymoma
  • +2 more
  • Sigle port RATS
  • Two ports RATS
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
May 18, 2022

Robotic Surgical Procedure, Thymoma, Myasthenia Gravis Trial (Da Vinci SP surgical platform)

Not yet recruiting
  • Robotic Surgical Procedure
  • +2 more
  • Da Vinci SP surgical platform
  • (no location specified)
Jul 8, 2022

Thymoma Type B3, Thymic Carcinoma Trial in Worldwide (Nivolumab)

Recruiting
  • Thymoma Type B3
  • Thymic Carcinoma
  • Brussel, Belgium
  • +19 more
Jul 1, 2022

Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &

Active, not recruiting
  • Thymoma
  • +2 more
  • Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
  • Duarte, California
  • +7 more
May 27, 2022

Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

Recruiting
  • Thymic Carcinoma
  • Envolizumab combined with radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 3, 2023

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Thymic Tumors Trial in Shanghai, Chengdu (KC1036)

Not yet recruiting
  • Thymic Tumors
  • Shanghai, Shanghai, China
  • +1 more
Jan 5, 2023

Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)

Recruiting
  • Lung Cancer
  • +8 more
  • Home-based cardiac rehabilitation
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 9, 2022

Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)

Recruiting
  • Thymoma
  • Radiotherapy Combined with GM-CSF
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 2, 2022

Single Cell Sequencing Analysis of Thymoma

Recruiting
  • Thymoma
  • Tissue
  • Hangzhou, China
    ZHAO AN
Jun 2, 2021

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Thymoma, Masaoka Stage I, Masaoka Stage II Trial in Shanghai (the subxiphoid approach thoracoscopic thymectomy, the lateral

Not yet recruiting
  • Thymoma
  • +2 more
  • the subxiphoid approach thoracoscopic thymectomy
  • the lateral intercostal approach thoracoscopic thymectomy
  • Shanghai, China
    Shanghai Zhongshan Hospital
Aug 3, 2021